Active Ingredient: CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE
Proprietary Name: CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 5MG;2.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A216419
Product Number: 001
Approval Date: Sep 14, 2023
Applicant Holder Full Name: AUROBINDO PHARMA LTD
Marketing Status:
Prescription
Patent and Exclusivity Information